» Articles » PMID: 24853882

Stress Triggers the Onset and the Recurrences of Hyperthyroidism in Patients with Graves' Disease

Overview
Journal Endocrine
Specialty Endocrinology
Date 2014 May 24
PMID 24853882
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to evaluate the relationship of stressful events (SE) with the onset and outcome of Graves' disease (GD). Over a period of 21 years, we enrolled 58 consecutive patients in whom at least one SE had occurred ≤12 months before the onset of GD. Patients were treated with antithyroid drugs (ATD) for ≥12 months and followed up for ≥5 years after ATD withdrawal. We divided patients in three groups: REM (who reached remission; 25.9%); EXA (who experienced ≥1 exacerbation during ATD; 10.3%); and REL (who experienced ≥1 relapse after ATD withdrawal; 63.8%). The average age at onset was similar in the three groups. All males aged ≤25 years at GD onset relapsed at least once; no patient aged ≥51 years at GD onset relapsed ≥2 times. All patients who exacerbated or relapsed had at least one SE preceding each exacerbation or relapse. The time lag between SE and onset of GD (19.3±11.9 weeks) correlated with the age at onset (r=0.292, P=0.0002), particularly in the REL group (r=0.346, P=0.001). Overall, EXA and REL patients experienced more SE than REM patients (P=0.0002 and P=0.003, respectively). In the REL group, the overall number of SE was correlated with the number of relapses (r=0.486, P<0.0001). There exist GD patients who are prone to develop hyperthyroidism and its recurrences when exposed to SE. They are relatively young; the younger these patients are, the shorter is the time lag between SE and the onset of hyperthyroidism.

Citing Articles

A case report of unilateral development of painful thyroiditis used as a hallmark of the nervous nature of its pathogenesis.

Ushakov A AME Case Rep. 2025; 9():13.

PMID: 39866277 PMC: 11760932. DOI: 10.21037/acr-24-97.


A beneficial levels of 25-hydroxyvitamin D for a decrease in thyrotropin receptor antibody (TRAB) in patients with Graves' disease: a real-world study.

Chen X, Zhang Y, Lin L, Chen Y, Shen X, Huang L BMC Endocr Disord. 2025; 25(1):14.

PMID: 39838313 PMC: 11748308. DOI: 10.1186/s12902-024-01823-x.


Autoimmune Thyroid Disease and Pregnancy: The Interaction Between Genetics, Epigenetics and Environmental Factors.

Bogovic Crncic T, Curko-Cofek B, Baticic L, Girotto N, Tomas M, Krsek A J Clin Med. 2025; 14(1.

PMID: 39797274 PMC: 11721206. DOI: 10.3390/jcm14010190.


A short review of current knowledge regarding long-term treatment of Graves' disease with antithyroid drugs.

Giordani I, Sykiotis G Hormones (Athens). 2024; .

PMID: 39636385 DOI: 10.1007/s42000-024-00618-y.


Causal effects of post-traumatic stress disorder on autoimmune thyroid disease: insights from mendelian randomization.

Chen Z, Yu Y, Yao J, Guo Z, Cui Y, Li F Front Psychiatry. 2024; 15:1417302.

PMID: 39371915 PMC: 11449846. DOI: 10.3389/fpsyt.2024.1417302.


References
1.
Morillo E, GARDNER L . Bereavement as an antecedent factor in thyrotoxicosis of childhood: four case studies with survey of possible metabolic pathways. Psychosom Med. 1979; 41(7):545-55. DOI: 10.1097/00006842-197911000-00005. View

2.
Winsa B, Adami H, Bergstrom R, Gamstedt A, Dahlberg P, Adamson U . Stressful life events and Graves' disease. Lancet. 1991; 338(8781):1475-9. DOI: 10.1016/0140-6736(91)92298-g. View

3.
Benvenga S . Benzodiazepine and remission of Graves' disease. Thyroid. 1996; 6(6):659-60. DOI: 10.1089/thy.1996.6.659. View

4.
Radosavljevic V, Jankovic S, Marinkovic J . Stressful life events in the pathogenesis of Graves' disease. Eur J Endocrinol. 1996; 134(6):699-701. DOI: 10.1530/eje.0.1340699. View

5.
Vita R, Lapa D, Vita G, Trimarchi F, Benvenga S . A patient with stress-related onset and exacerbations of Graves disease. Nat Clin Pract Endocrinol Metab. 2008; 5(1):55-61. DOI: 10.1038/ncpendmet1006. View